Immuneering Corp — Investor Relations & Filings
Filings indexed
300
across all filing types
Latest filing
2026-05-15
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
IMRX
Immuneering Corp. is a clinical-stage oncology company focused on developing medicines for broad populations of cancer patients. The company utilizes its proprietary computational Disease Cancelling Technology to design and develop novel therapeutics. Its lead product candidate, atebimetinib (IMM-1-104), is an oral, once-daily deep cyclic inhibitor of the MEK pathway. Atebimetinib is being evaluated in Phase 2a clinical trials for patients with advanced solid tumors, including pancreatic cancer. The drug is designed to maximize therapeutic activity while providing an improved tolerability profile, with the goal of helping patients outlive their disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-15 | English | |
| 8-K | 2026-05-15 | English | |
| 4 Filing | 2026-02-05 | English | |
| 4 Filing | 2026-02-05 | English | |
| 4 Filing | 2026-02-05 | English | |
| 4 Filing | 2026-02-05 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46353441 | 10-Q | 2026-05-15 | English | ||
| 46353436 | 8-K | 2026-05-15 | English | ||
| 31731541 | 4 Filing | 2026-02-05 | English | ||
| 31731482 | 4 Filing | 2026-02-05 | English | ||
| 31731473 | 4 Filing | 2026-02-05 | English | ||
| 31731465 | 4 Filing | 2026-02-05 | English | ||
| 31731434 | 4 Filing | 2026-02-05 | English | ||
| 31731427 | 4 Filing | 2026-02-05 | English | ||
| 31731413 | 4 Filing | 2026-02-05 | English | ||
| 31731511 | SCHEDULE 13G/A Filing | 2026-01-22 | English | ||
| 13211491 | FORM 4 | 2026-01-21 | English | ||
| 13211492 | FORM 4 | 2026-01-20 | English | ||
| 13211493 | FORM 4 | 2026-01-16 | English | ||
| 13211494 | Major Shareholding Notification 2026 | 2026-01-15 | English | ||
| 13211495 | FORM 4 | 2026-01-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
D.Western Therapeutics Institute, Inc.
Biotechnology firm developing drugs from a proprietary prot…
|
4576 | JP | Professional, scientific and te… |
|
Ecopia BioSciences Inc.
Developing novel anticancer agents and therapeutic solution…
|
EIA | CA | Professional, scientific and te… |
|
Ectin Research AB
Pharmaceutical company developing novel oncology treatments…
|
ECTIN B | SE | Professional, scientific and te… |
|
EdgeLab S.p.A.
Designs and manufactures marine and underwater solutions, i…
|
ELB | IT | Professional, scientific and te… |
|
Editas Medicine, Inc.
A clinical-stage genome editing company developing CRISPR m…
|
EDIT | US | Professional, scientific and te… |
|
EGF Theramed Health Corp.
Developing psychedelic drugs for mental health, diagnostic …
|
TMED | CA | Professional, scientific and te… |
|
Eikon Therapeutics, Inc.
Integrates live-cell imaging and computing to discover ther…
|
EIKN | US | Professional, scientific and te… |
|
Eledon Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for organ and a…
|
ELDN | US | Professional, scientific and te… |
|
Elicera Therapeutics AB
Clinical-stage immuno-oncology company developing cell and …
|
ELIC | SE | Professional, scientific and te… |
|
Elicio Therapeutics, Inc.
Clinical-stage biotech developing lymph node-targeted immun…
|
ELTX | US | Professional, scientific and te… |
Immuneering Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32973/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32973 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32973 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32973 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32973}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Immuneering Corp (id: 32973)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.